Haijun Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haijun Tang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chenming Liu
Department of General Surgery, Shaoxing People’s Hospital, Shaoxing, China
2 shared publications - Baochun Lu
Department of Hepatobiliary Surgery, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang 312000, P.R. China
1 shared publication - Fan Zhang
Affiliations School of Education, Shaanxi Normal University, Xi’an, China, E-commerce Department, Guangdong Electronic-Commerce Technician College, Guangdong, China
1 shared publication - Fang Meng
Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College; Suzhou Institute of Systems Medicine, Suzhou, China
1 shared publication - Frank Xiao‐Feng Qin
Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College; Suzhou Institute of Systems Medicine, Suzhou, China
1 shared publication - Huimin Tang
School of Management Guangzhou Xin Hua College, Guangzhou, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 19 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 223-228
Research on Product Pricing Strategies in Duopoly Markets under C2B Model
This paper analyzes the pricing strategies of sellers operating in duopoly markets under the Customer to Business (C2B) model. Our analysis reveals that consumers, when purchasing personalized customized products from two sellers, encounter four distinct quantity combinations. Factors such as the marginal utility of personalized customized products, the customization capability of C2B sellers, product substitutability between the two sellers, and consumer mismatch costs will affect the seller's revenue and consumer surplus.
- 19 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 223-228
Open AccessResearch on Product Pricing Strategies in Duopoly Markets under C2B Model
This paper analyzes the pricing strategies of sellers operating in duopoly markets under the Customer to Business (C2B) model. Our analysis reveals that consumers, when purchasing personalized customized products from two sellers, encounter four distinct quantity combinations. Factors such as the marginal utility of personalized customized products, the customization capability of C2B sellers, product substitutability between the two sellers, and consumer mismatch costs will affect the seller's revenue and consumer surplus.
- Open Access
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4483-4484
Splenic rupture mimicking acute abdomen caused by giant hydronephrosis: A thorny case
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4483-4484
Open AccessSplenic rupture mimicking acute abdomen caused by giant hydronephrosis: A thorny case
- Open Access
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4513-4515
Successful intervention of an impacted basket and duodenal perforation secondary to endoscopic retrograde cholangiopancreatography
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4513-4515
Open AccessSuccessful intervention of an impacted basket and duodenal perforation secondary to endoscopic retrograde cholangiopancreatography
- Open Access
- 13 October 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11, 720357
Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
SARS-coronavirus 2 (SARS-CoV-2), pathogen of coronavirus disease 2019 (COVID-19), is constantly evolving to adapt to the host and evade antiviral immunity. The newly emerging variants N501Y.V1 (B.1.1.7) and N501Y.V2 (B.1.351), first reported in the United Kingdom and South Africa respectively, raised concerns due to the unusually rapid global spread. The mutations in spike (S) protein may contribute to the rapid spread of these variants. Here, with a vesicular stomatitis virus (VSV)-based pseudotype system, we demonstrated that the pseudovirus bearing N501Y.V2 S protein has higher infection efficiency than pseudovirus with wildtype (WT) and D614G S protein. Moreover, pseudovirus with N501Y.V1 or N501Y.V2 S protein has better thermal stability than WT and D614G, suggesting these mutations of variants may increase the stability of SARS-CoV-2 S protein and virion. However, the pseudovirus bearing N501Y.V1 or N501Y.V2 S protein has similar sensitivity to inhibitors of protease and endocytosis with WT and D614G. These findings could be of value in preventing the spread of virus and developing drugs for emerging SARS-CoV-2 variants.
- 13 October 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11, 720357
Open AccessCharacterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
SARS-coronavirus 2 (SARS-CoV-2), pathogen of coronavirus disease 2019 (COVID-19), is constantly evolving to adapt to the host and evade antiviral immunity. The newly emerging variants N501Y.V1 (B.1.1.7) and N501Y.V2 (B.1.351), first reported in the United Kingdom and South Africa respectively, raised concerns due to the unusually rapid global spread. The mutations in spike (S) protein may contribute to the rapid spread of these variants. Here, with a vesicular stomatitis virus (VSV)-based pseudotype system, we demonstrated that the pseudovirus bearing N501Y.V2 S protein has higher infection efficiency than pseudovirus with wildtype (WT) and D614G S protein. Moreover, pseudovirus with N501Y.V1 or N501Y.V2 S protein has better thermal stability than WT and D614G, suggesting these mutations of variants may increase the stability of SARS-CoV-2 S protein and virion. However, the pseudovirus bearing N501Y.V1 or N501Y.V2 S protein has similar sensitivity to inhibitors of protease and endocytosis with WT and D614G. These findings could be of value in preventing the spread of virus and developing drugs for emerging SARS-CoV-2 variants.